{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and posted_year = 2013 sorted by posted_date descending", "rows": [["FDA-2013-V-1596-0001", "FDA", "FDA-2013-V-1596", "Duality- Application for Variance", "Other", "Application for Variance (VAR)", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", null, "2013-12-31T18:19:11Z", null, 0, 0, "09000064814b23ab"], ["FDA-1979-N-0409-0001", "FDA", "FDA-1979-N-0409", "Blood and Blood Components; Error and Accident Reports - Notice of Proposed Rule", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", "1980-11-07T04:59:59Z", "2014-05-08T14:18:07Z", null, 0, 0, "090000648055636a"], ["FDA-1979-N-0409-0003", "FDA", "FDA-1979-N-0409", "Regulatory Analysis Assessment for Proposed Rule Making for Blood and Blood Components Concerning Error and Accident Reports - Regulatory Analysis", "Supporting & Related Material", "Regulatory Analysis", "2013-12-31T05:00:00Z", 2013, 12, null, null, "2013-12-31T15:35:10Z", null, 0, 0, "09000064814e3e84"], ["FDA-2011-N-0922-0017", "FDA", "FDA-2011-N-0922", "Request for Extension from American Feed Industry Association", "Other", "Request for Extension", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", null, "2013-12-31T19:44:06Z", null, 0, 0, "0900006481492bbf"], ["FDA-1979-N-0409-0002", "FDA", "FDA-1979-N-0409", "Regulatory Analysis Assessment for Proposed Rule Making for Blood and Blood Components Concerning Error and Accident Reports - Regulatory Analysis", "Supporting & Related Material", "Regulatory Analysis", "2013-12-31T05:00:00Z", 2013, 12, null, null, "2013-12-31T15:28:51Z", null, 0, 0, "0900006480556369"], ["FDA-2013-V-1595-0001", "FDA", "FDA-2013-V-1595", "Create Nightclub - Application for Variance", "Other", "Application for Variance (VAR)", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", null, "2013-12-31T18:24:52Z", null, 0, 0, "09000064814b34bd"], ["FDA-1979-N-0028-0035", "FDA", "FDA-1979-N-0028", "Supplement from Colorcon", "Supporting & Related Material", "Supplement", "2013-12-31T05:00:00Z", 2013, 12, null, null, "2014-05-14T14:37:03Z", null, 0, 0, "0900006480553999"], ["FDA-1979-N-0028-0036", "FDA", "FDA-1979-N-0028", "Letter from SunChemical Corporation to FDA Dated March 20 1997", "Other", "Letter(s)", "2013-12-31T05:00:00Z", 2013, 12, "1998-04-15T04:00:00Z", null, "2015-04-01T19:48:32Z", null, 0, 0, "090000648055399b"], ["FDA-1979-N-0409-0020", "FDA", "FDA-1979-N-0409", "Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent", "Notice", "Notice of Intent", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", "1991-10-29T04:59:59Z", "2014-05-09T14:38:20Z", null, 0, 0, "090000648055637d"], ["FDA-2013-V-1596-0002", "FDA", "FDA-2013-V-1596", "Acknowledgement Letter to Duality", "Other", "Acknowledgement Letter/Receipt", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", null, "2013-12-31T18:19:19Z", null, 0, 0, "09000064814b34bb"], ["FDA-2013-V-1595-0002", "FDA", "FDA-2013-V-1595", "Acknowledgement Letter to Create Nightclub", "Other", "Acknowledgement Letter/Receipt", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", null, "2013-12-31T18:25:02Z", null, 0, 0, "09000064814b34bf"], ["FDA-1979-N-0409-0021", "FDA", "FDA-1979-N-0409", "Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal", "Notice", "Withdrawal", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", null, "2014-05-09T14:38:40Z", null, 0, 0, "090000648055637e"], ["FDA-2013-N-1317-0092", "FDA", "FDA-2013-N-1317", "Tentative Determination Regarding Partially Hydrogenated Oils; Request\nfor Comments and for Scientific Data and Information; Extension of\nComment Period", "Notice", "Extension of Comment Period", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", "2014-03-09T04:59:59Z", "2015-06-20T01:30:52Z", "2013-31294", 0, 0, "09000064814e42b9"], ["FDA-2013-N-1634-0001", "FDA", "FDA-2013-N-1634", "Request for Notification From Industry Organizations Interested in\nParticipating in Selection Process for a Nonvoting Industry Representative on the Food Advisory Committee and\nRequest for Nominations for a Nonvoting Industry Representative on\nthe Food Advisory Committee", "Notice", "General Notice", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", null, "2014-01-02T14:51:51Z", "2013-31321", 0, 0, "09000064814e428c"], ["FDA-2013-N-0001-0120", "FDA", "FDA-2013-N-0001", "Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2013-12-31T05:00:00Z", 2013, 12, "2013-12-31T05:00:00Z", null, "2014-01-02T15:01:22Z", "2013-31320", 0, 0, "09000064814e431a"], ["FDA-2013-V-1607-0001", "FDA", "FDA-2013-V-1607", "DJ Leo Entertainment - Application for Variance", "Other", "Application for Variance (VAR)", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T15:50:09Z", null, 0, 0, "09000064814baabb"], ["FDA-2013-V-1608-0002", "FDA", "FDA-2013-V-1608", "Acknowledgement Letter to Nu-Salt", "Other", "Acknowledgement Letter/Receipt", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T15:10:14Z", null, 0, 0, "09000064814ba667"], ["FDA-1980-N-0149-0002", "FDA", "FDA-1980-N-0149", "Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent", "Notice", "Notice of Intent", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", "1991-10-29T04:59:59Z", "2014-05-08T12:59:27Z", null, 0, 0, "09000064805bcf63"], ["FDA-1979-N-0309-0003", "FDA", "FDA-1979-N-0309", "Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal", "Notice", "Withdrawal", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2014-05-12T14:04:10Z", null, 0, 0, "09000064805551a5"], ["FDA-1980-N-0149-0003", "FDA", "FDA-1980-N-0149", "Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal", "Notice", "Withdrawal", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2014-05-08T13:00:01Z", null, 0, 0, "09000064805bcf64"], ["FDA-2013-P-1611-0002", "FDA", "FDA-2013-P-1611", "Acknowledgement Letter to Clarissa Clarke", "Other", "Acknowledgement Letter/Receipt", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2024-07-25T12:19:07Z", null, 0, 0, "09000064814ba8c7"], ["FDA-2013-N-1676-0001", "FDA", "FDA-2013-N-1676", "International Drug Scheduling; Convention on Psychotropic\nSubstances; Single Convention on Narcotic Drugs; Tapentadol; Tramadol;\nKetamine; gamma-Butyrolactone; 22 Additional Substances; Request for\nComments", "Notice", "Request for Comments", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", "2014-01-30T04:59:59Z", "2024-11-07T23:00:25Z", "2013-31212", 1, 0, "09000064814e192b"], ["FDA-2013-V-1599-0001", "FDA", "FDA-2013-V-1599", "The Living Room - Application for Variance", "Other", "Application for Variance (VAR)", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T14:58:50Z", null, 0, 0, "09000064814b6fb0"], ["FDA-2013-V-1599-0002", "FDA", "FDA-2013-V-1599", "Acknowledgement Letter to The Living Room", "Other", "Acknowledgement Letter/Receipt", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T14:58:51Z", null, 0, 0, "09000064814b6ff2"], ["FDA-2013-N-0002-0045", "FDA", "FDA-2013-N-0002", "New Animal Drugs for Use in Animal Feeds; Bambermycins; Correction", "Rule", "Correction", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T15:28:01Z", "2013-31184", 0, 0, "09000064814e1974"], ["FDA-1979-N-0307-0001", "FDA", "FDA-1979-N-0307", "Allergenic Products; Proposed Testing and Labeling Requirements; Proposed Rule", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", "1980-07-02T03:59:59Z", "2014-06-18T16:36:34Z", null, 0, 0, "090000648055517f"], ["FDA-1979-N-0028-0014", "FDA", "FDA-1979-N-0028", "Comment from Colorcon, Inc. re FDA-1979-N-0028-0040", "Supporting & Related Material", "Background Material", "2013-12-30T05:00:00Z", 2013, 12, null, null, "2015-02-13T18:50:40Z", null, 0, 0, "0900006480553968"], ["FDA-1979-N-0084-0002", "FDA", "FDA-1979-N-0084", "Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent", "Notice", "Notice of Intent", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", "1991-10-29T04:59:59Z", "2014-05-12T18:35:27Z", null, 0, 0, "0900006480553e83"], ["FDA-1979-N-0309-0001", "FDA", "FDA-1979-N-0309", "Additional Standards for Human Blood Products; Antihemophillic Factor (Human) - Notice of Proposed Rule", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2014-05-13T14:33:51Z", null, 0, 0, "090000648055519b"], ["FDA-1979-N-0084-0001", "FDA", "FDA-1979-N-0084", "Food Labeling; Net Weight Labeling Requirements - Notice of Proposed Rule", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", "1980-11-07T04:59:59Z", "2014-05-12T18:31:25Z", null, 0, 0, "0900006480553e82"], ["FDA-2012-N-1239-0004", "FDA", "FDA-2012-N-1239", "Dental Devices; Reclassification of Temporary Mandibular Condyle\nProsthesis", "Rule", "Final Rule", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T15:21:52Z", "2013-31217", 0, 0, "09000064814e1b8c"], ["FDA-2013-V-1607-0002", "FDA", "FDA-2013-V-1607", "Acknowledgement Letter to DJ Leo Entertainment", "Other", "Acknowledgement Letter/Receipt", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T15:50:09Z", null, 0, 0, "09000064814baabd"], ["FDA-2013-V-1608-0001", "FDA", "FDA-2013-V-1608", "Nu-Salt - Application for Variance", "Other", "Application for Variance (VAR)", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T15:10:13Z", null, 0, 0, "09000064814ba665"], ["FDA-2013-N-0581-0002", "FDA", "FDA-2013-N-0581", "Cardiovascular Devices; Reclassification of Intra-Aortic Balloon\nand Control Systems for Acute Coronary Syndrome, Cardiac and Non-\nCardiac Surgery, or Complications of Heart Failure; Effective Date of\nRequirement for Premarket Approval for Intra-Aortic Balloon and Control\nSystems for Septic Shock or Pulsatile Flow Generation", "Rule", "Final Rule", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T14:52:49Z", "2013-31218", 0, 0, "09000064814e1976"], ["FDA-2013-P-1609-0001", "FDA", "FDA-2013-P-1609", "Lachman Consultant Services, Inc. - Citizen Petition", "Other", "Citizen Petition", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2024-11-07T22:59:08Z", null, 1, 0, "09000064814ba5ba"], ["FDA-2013-N-1155-0002", "FDA", "FDA-2013-N-1155", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Food Labeling\nRegulations", "Notice", "General Notice", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", "2014-01-30T04:59:59Z", "2014-01-25T02:04:00Z", "2013-31215", 0, 0, "09000064814e19fd"], ["FDA-2013-N-0001-0119", "FDA", "FDA-2013-N-0001", "Strategies To Address Hemolytic Complications of Immune Globulin\nInfusions; Public Workshop", "Notice", "Public Meetings", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T14:17:54Z", "2013-31213", 0, 0, "09000064814e18f0"], ["FDA-2013-P-1623-0001", "FDA", "FDA-2013-P-1623", "Sigmapharm Laboratories, LLC - Citizen Petition", "Other", "Citizen Petition", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2019-07-08T13:35:40Z", null, 0, 0, "09000064814bd194"], ["FDA-2013-N-0487-0004", "FDA", "FDA-2013-N-0487", "Cardiovascular Devices; Reclassification of External Counter-\nPulsating Devices for Treatment of Chronic Stable Angina; Effective Date\nof Requirement for Premarket Approval for External Counter-\nPulsating Devices for Other Specified Intended Uses", "Rule", "Final Rule", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T14:58:02Z", "2013-31216", 0, 0, "09000064814e1adf"], ["FDA-1979-N-0307-0003", "FDA", "FDA-1979-N-0307", "Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Withdrawal of Proposed Rule", "Notice", "Withdrawal", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T18:42:25Z", null, 0, 0, "0900006480555185"], ["FDA-1979-N-0309-0011", "FDA", "FDA-1979-N-0309", "Background Material Items 4 and 5; Appendices I through V", "Supporting & Related Material", "Background Material", "2013-12-30T05:00:00Z", 2013, 12, null, null, "2014-05-12T15:05:06Z", null, 0, 0, "0900006480555199"], ["FDA-1979-N-0309-0012", "FDA", "FDA-1979-N-0309", "Background Material items 1 and 2", "Supporting & Related Material", "Environmental Impact Analysis Report", "2013-12-30T05:00:00Z", 2013, 12, null, null, "2014-05-12T15:18:55Z", null, 0, 0, "0900006480555198"], ["FDA-1979-N-0309-0010", "FDA", "FDA-1979-N-0309", "Background Material Items 2 and 3", "Supporting & Related Material", "Regulatory Analysis", "2013-12-30T05:00:00Z", 2013, 12, null, null, "2014-05-12T14:42:31Z", null, 0, 0, "090000648055519a"], ["FDA-1979-N-0307-0004", "FDA", "FDA-1979-N-0307", "Regulatory Analysis Assessment for Proposed Rule Making Concerning Allergenic Products - Regulatory Assessment", "Supporting & Related Material", "Regulatory Analysis", "2013-12-30T05:00:00Z", 2013, 12, null, null, "2014-05-14T13:06:09Z", null, 0, 0, "090000648055517d"], ["FDA-2013-P-1623-0002", "FDA", "FDA-2013-P-1623", "Acknowledgement Letter to Sigmapharm Laboratories LLC", "Other", "Acknowledgement Letter/Receipt", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T16:12:16Z", null, 0, 0, "09000064814bd198"], ["FDA-1980-N-0149-0009", "FDA", "FDA-1980-N-0149", "Proposed Rule - Quality Control Testing of Platelet Concentrate (Human) and Cryoprecipitated Antihemophilic Factor (Human) - Regulatory Analysis Assessment", "Supporting & Related Material", "Regulatory Analysis", "2013-12-30T05:00:00Z", 2013, 12, null, null, "2013-12-30T18:35:48Z", null, 0, 0, "09000064805bcf5c"], ["FDA-2013-N-1425-0003", "FDA", "FDA-2013-N-1425", "List of References From PRIA Reference 65", "Other", "List (LST)", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T14:09:49Z", null, 0, 0, "09000064814e179f"], ["FDA-1979-N-0307-0002", "FDA", "FDA-1979-N-0307", "Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent", "Notice", "Notice of Intent", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", "1991-10-29T04:59:59Z", "2013-12-30T18:42:24Z", null, 0, 0, "0900006480555184"], ["FDA-1980-N-0149-0001", "FDA", "FDA-1980-N-0149", "Withdrawal of Certain Pre-1986 Proposed Rules - Notice of Proposed Rulemaking", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2014-05-08T12:45:51Z", null, 0, 0, "09000064805bcf5d"], ["FDA-2013-P-1609-0002", "FDA", "FDA-2013-P-1609", "Acknowledgement Letter to Lachman Consultant Services, Inc.", "Other", "Citizen Petition", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2013-12-30T16:00:10Z", null, 0, 0, "09000064814ba662"], ["FDA-1979-N-0084-0004", "FDA", "FDA-1979-N-0084", "Memorandum from FDA CFSAN to DDM", "Other", "Memorandum", "2013-12-30T05:00:00Z", 2013, 12, null, null, "2014-05-12T18:38:57Z", null, 0, 0, "0900006480553e85"], ["FDA-1979-N-0084-0003", "FDA", "FDA-1979-N-0084", "Food Labeling; Net Weight Labeling Requirements - Withdrawal of Certain Pre-1986 Proposed Rules; Final Action - Notice of Withdrawal", "Notice", "Withdrawal", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2014-05-12T18:35:45Z", null, 0, 0, "0900006480553e84"], ["FDA-1979-N-0309-0002", "FDA", "FDA-1979-N-0309", "Withdrawal of Certain Pre-1986 Proposed Rules; Opportunity for Public Comment - Notice of Intent", "Notice", "Notice of Intent", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", "1991-10-29T04:59:59Z", "2014-05-12T14:03:52Z", null, 0, 0, "09000064805551a4"], ["FDA-2013-P-1611-0001", "FDA", "FDA-2013-P-1611", "Citizen Petition from Clarissa Clarke", "Other", "Citizen Petition", "2013-12-30T05:00:00Z", 2013, 12, "2013-12-30T05:00:00Z", null, "2024-07-25T12:18:51Z", null, 0, 0, "09000064814ba6d2"], ["FDA-1977-N-0005-0367", "FDA", "FDA-1977-N-0005", "FDA/Office of Legislative Affairs to Hess & Clark, Inc. - Answer", "Other", "Answer", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", null, "2013-12-27T15:16:38Z", null, 0, 0, "09000064805d7d65"], ["FDA-2013-N-0002-0049", "FDA", "FDA-2013-N-0002", "Approvals of New Animal Drug Applications Withdrawals Roxarsone", "Rule", "Final Rule", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", null, "2014-01-25T23:25:40Z", "2013-30837", 0, 0, "09000064814de405"], ["FDA-2013-N-0002-0044", "FDA", "FDA-2013-N-0002", "Withdrawal of Approval of New Animal Drug Applications; Roxarsone", "Rule", "Final Rule", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", null, "2013-12-27T15:39:48Z", "2013-30838", 0, 0, "09000064814de527"], ["FDA-2011-P-0438-0006", "FDA", "FDA-2011-P-0438", "FDA/CDRH Response to Public Citizen Health Research Group - Partial Petition Approval and Denial", "Other", "Partial Petition Approval and Denial", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", null, "2013-12-27T12:55:24Z", null, 0, 0, "09000064814ddf89"], ["FDA-2013-N-0500-0006", "FDA", "FDA-2013-N-0500", "Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products; Correction and Extension of Comment Period", "Proposed Rule", "Extension of Comment Period", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", "2014-03-14T03:59:59Z", "2014-04-10T01:02:03Z", "2013-30881", 0, 0, "09000064814debad"], ["FDA-1977-N-0005-0357", "FDA", "FDA-1977-N-0005", "Definitions and General Considerations; Revised Procedures re Medicated Feed Applications - Notice of Extension of Comment Period", "Notice", "Notice of Extension", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", "1981-07-09T03:59:59Z", "2013-12-27T14:11:12Z", null, 0, 0, "09000064805d7b84"], ["FDA-2013-N-1147-0002", "FDA", "FDA-2013-N-1147", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Preparing a Claim\nof Categorical Exclusion or an Environmental Assessment for Submission to the Center for Food Safety and Applied Nutrition", "Notice", "General Notice", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", "2014-01-28T04:59:59Z", "2013-12-27T15:48:56Z", "2013-30998", 0, 0, "09000064814de952"], ["FDA-2011-N-0179-0019", "FDA", "FDA-2011-N-0179", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002", "Notice", "General Notice", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", "2014-01-28T04:59:59Z", "2014-04-04T17:00:53Z", "2013-30996", 0, 0, "09000064814deaed"], ["FDA-2013-N-1558-0001", "FDA", "FDA-2013-N-1558", "Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry and Food and Drug Administration Staff; Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products", "Notice", "60 Day Proposed Information Collection", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", "2014-02-26T04:59:59Z", "2015-02-14T00:29:34Z", "2013-30880", 0, 0, "09000064814debdd"], ["FDA-1977-N-0005-0385", "FDA", "FDA-1977-N-0005", "FDA/Office of Legislative Affairs to Cooper Evans  - Answer", "Other", "Answer", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", null, "2013-12-27T16:52:54Z", null, 0, 0, "09000064805d7d66"], ["FDA-1977-N-0005-0366", "FDA", "FDA-1977-N-0005", "Department of Health & Human Services, Public Health Service, Region 5 - Letter", "Other", "Letter(s)", "2013-12-27T05:00:00Z", 2013, 12, "2013-12-27T05:00:00Z", null, "2013-12-27T15:11:24Z", null, 0, 0, "09000064805d7b8f"], ["FDA-2013-N-1620-0001", "FDA", "FDA-2013-N-1620", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Information From United States Firms and Processors\nThat Export to the European Community", "Notice", "General Notice", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", "2014-02-25T04:59:59Z", "2024-11-07T23:00:22Z", "2013-30804", 1, 0, "09000064814dcb64"], ["FDA-2013-M-1605-0001", "FDA", "FDA-2013-M-1605", "Premarket Approval of W.L. Gore and Associates, Inc. P130006", "Other", "Approval", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", null, "2013-12-26T15:12:16Z", null, 0, 0, "09000064814dab0f"], ["FDA-2013-E-1694-0002", "FDA", "FDA-2013-E-1694", "TriVascular, Inc. - Patent Term Application", "Other", "Application", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", null, "2013-12-26T17:49:36Z", null, 0, 0, "09000064814dd643"], ["FDA-2013-E-1694-0001", "FDA", "FDA-2013-E-1694", "U.S. Patant and Trademark Office - Letter", "Other", "Letter(s)", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", null, "2013-12-26T17:49:28Z", null, 0, 0, "09000064814dd644"], ["FDA-2013-E-1691-0001", "FDA", "FDA-2013-E-1691", "U.S.. Patatent and Trademark Office - Letter", "Other", "Letter(s)", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", null, "2013-12-26T14:10:36Z", null, 0, 0, "09000064814dc7e9"], ["FDA-2013-D-1566-0002", "FDA", "FDA-2013-D-1566", "Draft Guidance for Industry on Naming of Drug Products Containing Salt Drug Substances", "Other", "Guidance", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", null, "2024-11-07T23:00:18Z", null, 1, 0, "09000064814dcd46"], ["FDA-2013-N-0001-0118", "FDA", "FDA-2013-N-0001", "Allergenic Products Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", null, "2013-12-26T14:51:40Z", "2013-30799", 0, 0, "09000064814dc88e"], ["FDA-2013-E-1692-0001", "FDA", "FDA-2013-E-1692", "U.S. Patent and Trademark Office - Letter", "Other", "Letter(s)", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", null, "2013-12-26T14:45:07Z", null, 0, 0, "09000064814dc7ee"], ["FDA-2013-E-0296-0003", "FDA", "FDA-2013-E-0296", "U.S. Patent and Trademark Office - Letter", "Other", "Letter(s)", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", null, "2013-12-26T15:48:59Z", null, 0, 0, "09000064814dcd48"], ["FDA-2013-N-1618-0001", "FDA", "FDA-2013-N-1618", "Draft Prescription Drug User Fee Act V Information Technology Plan;\nAvailability for Comment", "Notice", "General Notice", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", "2014-02-25T04:59:59Z", "2024-11-07T23:00:00Z", "2013-30818", 1, 0, "09000064814dc9f4"], ["FDA-1977-N-0005-0329", "FDA", "FDA-1977-N-0005", "FDA/Office of Legislative Affairs to the Honorable Paul Findley  - Comment", "Other", "Answer", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", null, "2013-12-26T18:05:15Z", null, 0, 0, "09000064805d7d64"], ["FDA-2013-E-1691-0002", "FDA", "FDA-2013-E-1691", "Morrison & Foerster LLP (on behalf of Genenetech, Inc) - Patent Term Application", "Other", "Application", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", null, "2013-12-26T14:27:36Z", null, 0, 0, "09000064814db700"], ["FDA-2013-E-1690-0002", "FDA", "FDA-2013-E-1690", "CEPHALON, Inc. -  Patent Term Application", "Other", "Application", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", null, "2013-12-26T13:38:09Z", null, 0, 0, "09000064814db6fc"], ["FDA-2013-E-1692-0002", "FDA", "FDA-2013-E-1692", "Morrison & Foerster LLP (on behalf of Genenetech, Inc) - Patent Term Application", "Other", "Application", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", null, "2013-12-26T14:45:22Z", null, 0, 0, "09000064814dc7ed"], ["FDA-2013-N-1615-0002", "FDA", "FDA-2013-N-1615", "16452 GDUFA IT Plan", "Supporting & Related Material", "Background Material", "2013-12-26T05:00:00Z", 2013, 12, null, null, "2013-12-26T16:58:52Z", null, 0, 0, "09000064814dd570"], ["FDA-2013-D-1566-0001", "FDA", "FDA-2013-D-1566", "Draft Guidance for Industry on Naming of Drug Products Containing Salt Drug Substances; Availability", "Notice", "Notice of Availability", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", "2014-03-27T03:59:59Z", "2014-03-27T01:02:38Z", "2013-30800", 0, 0, "09000064814dcb61"], ["FDA-2013-E-1690-0001", "FDA", "FDA-2013-E-1690", "U.S. Patent and Trademark Office - Letter", "Other", "Letter(s)", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", null, "2013-12-26T13:38:00Z", null, 0, 0, "09000064814db6fd"], ["FDA-2013-N-1618-0002", "FDA", "FDA-2013-N-1618", "16451 PDUFA IT Plan", "Supporting & Related Material", "Background Material", "2013-12-26T05:00:00Z", 2013, 12, null, null, "2013-12-26T17:04:34Z", null, 0, 0, "09000064814dd571"], ["FDA-2013-N-1615-0001", "FDA", "FDA-2013-N-1615", "Draft Generic Drug User Fee Act Information Technology Plan;\nAvailability for Comment", "Notice", "General Notice", "2013-12-26T05:00:00Z", 2013, 12, "2013-12-26T05:00:00Z", "2014-02-25T04:59:59Z", "2014-02-25T02:03:09Z", "2013-31008", 0, 0, "09000064814dcba6"], ["FDA-2013-N-0001-0117", "FDA", "FDA-2013-N-0001", "Science Advisory Board to the National Center for Toxicological\nResearch; Notice of Meeting", "Notice", "Meeting", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2013-12-24T14:55:25Z", "2013-30578", 0, 0, "09000064814d558a"], ["FDA-2009-E-0087-0013", "FDA", "FDA-2009-E-0087", "U.S. Patent and Trademark Office to Zoetis - Letter", "Other", "Letter(s)", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2013-12-24T13:04:38Z", null, 0, 0, "09000064814d407b"], ["FDA-2013-V-1559-0002", "FDA", "FDA-2013-V-1559", "Acknowledgement Letter to Coast Digital Solutions, Inc.", "Other", "Acknowledgement Letter/Receipt", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2013-12-24T18:13:20Z", null, 0, 0, "09000064814a5fa4"], ["FDA-2013-N-1563-0001", "FDA", "FDA-2013-N-1563", "Appendix 4 to Draft Qualitative Risk Assessment of Risk of Activity/Food\nCombinations for Activities (Outside the Farm Definition) Conducted in a\nFacility Co-Located on a Farm; Availability", "Proposed Rule", "Request for Comment", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", "2014-04-01T03:59:59Z", "2014-01-01T02:04:13Z", "2013-30375", 0, 0, "09000064814d536f"], ["FDA-2013-V-1559-0001", "FDA", "FDA-2013-V-1559", "Coast Digital Solutions, Inc. - Application for Variance", "Other", "Application for Variance (VAR)", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2013-12-24T18:13:19Z", null, 0, 0, "09000064814a5f9f"], ["FDA-2013-E-0682-0004", "FDA", "FDA-2013-E-0682", "U.S. Patent and Trademark Office to Venable LLP - Letter", "Other", "Letter(s)", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2013-12-24T13:23:43Z", null, 0, 0, "09000064814d407d"], ["FDA-2013-N-1496-0001", "FDA", "FDA-2013-N-1496", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Food and Drug Administration Rapid Response\nSurveys (Generic Clearance)", "Notice", "General Notice", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", "2014-02-25T04:59:59Z", "2013-12-24T15:06:13Z", "2013-30630", 0, 0, "09000064814d55d8"], ["FDA-2013-V-1560-0002", "FDA", "FDA-2013-V-1560", "Acknowledgement Letter to Davaine Lighting", "Other", "Acknowledgement Letter/Receipt", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2013-12-24T18:19:41Z", null, 0, 0, "09000064814a5c89"], ["FDA-2013-V-1560-0001", "FDA", "FDA-2013-V-1560", "Davaine Lighting - Application for Variance", "Other", "Application for Variance (VAR)", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2013-12-24T18:19:25Z", null, 0, 0, "09000064814a5c85"], ["FDA-2013-P-0380-0003", "FDA", "FDA-2013-P-0380", "FDA/CDER Interim Response to the University of Florida College of Medicine - Jacksonville and the UNC School of Medicine - Letter", "Other", "Letter(s)", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2015-07-07T22:14:36Z", null, 0, 0, "09000064814414e8"], ["FDA-2011-P-0086-0006", "FDA", "FDA-2011-P-0086", "Janssen Research & Development, LLC. - Supplement", "Other", "Supplement (SUP)", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2013-12-24T20:07:39Z", null, 0, 0, "09000064814ba9d1"], ["FDA-2012-N-0284-0009", "FDA", "FDA-2012-N-0284", "FDA CDER Memorandum December 17 2013 re for use of Sodium Nitroprusside to Reduce Blood Pressure  in Pediatric Patients", "Other", "Memorandum", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2013-12-24T13:59:09Z", null, 0, 0, "09000064814d51b8"], ["FDA-2013-N-1425-0001", "FDA", "FDA-2013-N-1425", "Focused Mitigation Strategies To Protect Food Against Intentional\nAdulteration; Public Meeting on Proposed Rule", "Proposed Rule", "Public Meeting", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2013-12-24T15:38:06Z", "2013-30372", 0, 0, "09000064814d54bf"], ["FDA-2013-N-0001-0115", "FDA", "FDA-2013-N-0001", "Ophthalmic Devices Panel of the Medical Devices Advisory Committee;\nNotice of Meeting", "Notice", "Meeting", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2013-12-24T14:49:23Z", "2013-30579", 0, 0, "09000064814d52cb"], ["FDA-2013-N-1425-0002", "FDA", "FDA-2013-N-1425", "Focused Mitigation Strategies to Protect Food Against Intentional Adulteration", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", "2014-04-01T03:59:59Z", "2014-04-04T01:02:32Z", "2013-30373", 0, 0, "09000064814d53fc"], ["FDA-2013-N-0001-0116", "FDA", "FDA-2013-N-0001", "Orthopaedic and Rehabilitation Devices Panel of the Medical Devices\nAdvisory Committee; Notice of Meeting", "Notice", "Meeting", "2013-12-24T05:00:00Z", 2013, 12, "2013-12-24T05:00:00Z", null, "2013-12-24T14:52:21Z", "2013-30580", 0, 0, "09000064814d531a"]], "truncated": false, "filtered_table_rows_count": 7453, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "2013"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&posted_year=2013", "results": [{"value": "FDA", "label": "FDA", "count": 7453, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?posted_year=2013", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&posted_year=2013", "results": [{"value": "Other", "label": "Other", "count": 6331, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2013&document_type=Other", "selected": false}, {"value": "Notice", "label": "Notice", "count": 718, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2013&document_type=Notice", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 222, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2013&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 107, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2013&document_type=Proposed+Rule", "selected": false}, {"value": "Rule", "label": "Rule", "count": 75, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2013&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&posted_year=2013", "results": [{"value": 2013, "label": 2013, "count": 7453, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2013&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2013&_facet=open_for_comment"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2013&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2013&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2013&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2013&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2013&_facet_date=last_modified"}], "next": "2013-12-24T05~3A00~3A00Z,FDA-2013-N-0001-0116", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2013&_next=2013-12-24T05~3A00~3A00Z%2CFDA-2013-N-0001-0116&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 1053.6817440297455, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}